Evidence map›Paper›PMID 17096142›Full record

ArticleParasitology research2007

Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83.

Monte-Alegre Adriano, Baptiste Vergnes, Joel Poncet, Françoise Mathieu-Daude, Anabela Cordeiro da Silva, Ali Ouaissi, Denis Sereno

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Sirtuins of parasitic protozoa: in search of function(s).Molecular and biochemical parasitology · 2012
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Monte-Alegre AdrianoUR008 Pathogénie des Trypanosomatidés, Centre IRD de Montpellier, 911 Avenue Agropolis, Montpellier, 34394, France.
Baptiste Vergnes
Joel Poncet
Françoise Mathieu-Daude
Anabela Cordeiro da Silva
Ali Ouaissi
Denis Sereno
Institut de Recherche pour le Développement · FRAgropolis International · FRInstitut de Génomique Fonctionnelle · FRUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytoplasmic Leishmania silent information regulator 2 (SIR2)RP1 protein is essential for parasite growth and survival and constitutes an attractive therapeutic target. Little information is available on putative substrate(s) and/or partner(s) that could shed light on the pathways in which this enzyme plays a role. We carried out co-immunoprecipitation experiments on the soluble fractions of wild-type and parasites overexpressing LmSIR2RP1 and found that the essential chaperone heat shock protein (HSP) 83, the Leishmania ortholog of the mammalian HSP90, constantly co-immunoprecipitated with LmSIR2RP1. We found that Leishmania HSP83 is among the lysine acetylated protein, but the intracellular level of SIR2RP1 does not influence the acetylation status of HSP83. Finally, the modified Geldanamycin susceptibility (an inhibitor of HSP83) exhibited by SIR2RP1 mutant parasites support an in vivo relationship between the chaperone activity of HSP83 and LmSIR2RP1. An insight on the nature of the interaction in Leishmania is required to understand its role in the cell fate control during cytodifferentiation.

Indexed as

Amino Acid SequenceAnimalsGene Expression RegulationHeat-Shock ProteinsLeishmaniaMutationNuclear ProteinsProtozoan ProteinsHeat-Shock ProteinsHsp83 protein, protozoanNuclear ProteinsProtozoan Proteins

Identifiers

PMID17096142
OpenAlexW2023411386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.